Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Mathur P, Sathishkumar K, Chaturvedi M,  et al. Cancer Statistics, 2020: report from National Cancer Registry Programme, India. JCO Glob Oncol. 2020;6:1063–75. https://doi.org/10.1200/GO.20.00122.

Ibrahim M, Gilbert K. Management of gastric cancer in Indian population. Transl Gastroenterol Hepatol. 2017;2:64.

Article  PubMed  PubMed Central  Google Scholar 

Ramachandra, Goel V, Raju K, et al. Prospective randomized controlled study comparing primary surgery versus neoadjuvant chemotherapy followed by surgery in gastric carcinoma. Indian J Surg Oncol. 2019;10:245–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ramaswamy A, Bhargava P, Ostwal V. Real-world long-term outcomes with perioperative EOX in D2 gastrectomy: a meaningful look while we switch to FLOT-4. J Gastrointest Cancer. 2020;51:703–8.

Article  CAS  PubMed  Google Scholar 

Kumar S, Seshadri RA, Trivadi SG, Dhanushkodi M, Ellusamy HR. Perioperative versus postoperative chemotherapy for gastric cancer: a propensity score matched analysis. Asia Pac J Clin Oncol. 2020;16:e252–6.

Article  PubMed  Google Scholar 

Shrikhande SV, Shukla PJ, Qureshi S,  et al. D2 lymphadenectomy for gastric cancer in Tata Memorial Hospital: Indian data can now be incorporated in future international trials. Dig Surg. 2006;23:192–7.

Article  PubMed  Google Scholar 

Sankaranarayanan R, Black RJ, Swaminathan R, Parkin DM. An overview of cancer survival in developing countries. IARC Sci Publ. 1998;135–73.

Dikshit RP, Mathur G, Mhatre S, Yeole BB. Epidemiological review of gastric cancer in India. Indian J Med Paediatr Oncol. 2011;32:3–11.

Article  PubMed  PubMed Central  Google Scholar 

Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385:977–1010.

Article  PubMed  Google Scholar 

Dikshit R, Gupta PC, Ramasundarahettige C, et al. Cancer mortality in India: a nationally representative survey. Lancet. 2012;379:1807–16.

Article  PubMed  Google Scholar 

Cancer among adolescents and young adults (AYAs) - Cancer Stat Facts [Internet]. SEER. Available from: https://seer.cancer.gov/statfacts/html/aya.html. Accessed 17 August 2023.

Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM. Ann Surg Oncol. 2010;17:1471–4.

Article  PubMed  Google Scholar 

CDC. All About Adult BMI [Internet]. Centers for Disease Control and Prevention; 2022. Available from: https://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/index.html. Accessed 9 March 2023.

Common Terminology Criteria for Adverse Events (CTCAE) | Protocol Development | CTEP [Internet]. Available from: https://ctep.cancer.gov/protocoldevelopment/electronic_applications/ctc.htm. Accessed 9 March 2023.

GBD 2017 Stomach Cancer Collaborators. The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017. Lancet Gastroenterol Hepatol. 2020;5:42–54.

Article  Google Scholar 

Report of National Cancer Registry Programme; 2020 [Internet]. Available from: https://ncdirindia.org/All_Reports/Report_2020/default.aspx. Accessed 6 June 2023.

Servarayan Murugesan C, Manickavasagam K, Chandramohan A, et al. Gastric cancer in India: epidemiology and standard of treatment. Updates Surg. 2018;70:233–9.

Article  Google Scholar 

Milano AF. 20-year comparative survival and mortality of cancer of the stomach by age, sex, race, stage, grade, cohort entry time-period, disease duration & selected ICD-O-3 oncologic phenotypes: a systematic review of 157,258 cases for diagnosis years 1973-2014: (SEER*Stat 8.3.4). J Insur Med. 2019;48:5–23.

Article  PubMed  Google Scholar 

Smyth EC, Verheij M, Allum W, et al. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27:v38-49.

Article  CAS  PubMed  Google Scholar 

Zhao J, Gao P, Song Y, et al. Which is better for gastric cancer patients, perioperative or adjuvant chemotherapy: a meta-analysis. BMC Cancer. 2016;16:631.

Article  PubMed  PubMed Central  Google Scholar 

Ding XW, Zheng ZC, Zhao Q, et al. A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data. Zhonghua Wei Chang Wai Ke Za Zhi. 2021;24:403–12.

CAS  PubMed  Google Scholar 

Li Y, Ma F-H, Xue L-Y, Tian Y-T. Neoadjuvant chemotherapy vs upfront surgery for gastric signet ring cell carcinoma: a retrospective, propensity score-matched study. World J Gastroenterol. 2020;26:818–27.

Article  PubMed  PubMed Central  Google Scholar 

Cunningham D, Allum WH, Stenning SP, et al. MAGIC Trial Participants. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11–20. https://doi.org/10.1056/NEJMoa055531.

Riihimäki M, Hemminki A, Sundquist K, Sundquist J, Hemminki K. Metastatic spread in patients with gastric cancer. Oncotarget. 2016;7:52307–16.

Article  PubMed  PubMed Central  Google Scholar 

Sirohi B, Rastogi S, Dawood S,  et al. Treatment of patients with advanced gastric cancer: experience from an Indian tertiary cancer center. Med Oncol. 2014;31:138.

Article  PubMed  Google Scholar 

Wagner AD, Grothe W, Haerting J, Kleber G, Grothey A, Fleig WE. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol. 2006;24:2903–9.

Article  CAS  PubMed  Google Scholar 

Glimelius B, Ekström K, Hoffman K, et al. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol. 1997;8:163–8.

Article  CAS  PubMed  Google Scholar 

Bouché O, Raoul JL, Bonnetain F, et al. Randomized multicenter phase II trial of a biweekly regimen of fluorouracil and leucovorin (LV5FU2), LV5FU2 plus cisplatin, or LV5FU2 plus irinotecan in patients with previously untreated metastatic gastric cancer: a Federation Francophone de Cancerologie Digestive Group Study–FFCD 9803. J Clin Oncol. 2004;22:4319–28.

Article  PubMed  Google Scholar 

Cunningham D, Starling N, Rao S, et al. Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med. 2008;358:36–46.

Article  CAS  PubMed  Google Scholar